Balovaptan

Unassigned

New Medicines

Autism spectrum disorder (ASD)

Information

New molecular entity
Roche
Roche

Development and Regulatory status

Phase III Clinical Trials
Phase III Clinical Trials
Phase III Clinical Trials

Category

Vasopressin 1a (V1a) receptor antagonist
It is estimated that about 1% of adults have ASD. The prevalence in children is also around 1%. ASD is more commonly diagnosed in boys than in girls, with a ratio of approximately 4:1, although this varies across the spectrum of ASD. [1]
Autism spectrum disorder (ASD)
Oral